Prostate Cancer

Antitumor Activity Seen With Keytruda In Mcrpc

]]>(MedPage Today) -- Pembrolizumab (Keytruda) monotherapy demonstrated antitumor activity with manageable safety in a small subgroup of men with previously treated metastatic castrate-resistant prostate cancer (mCRPC), researchers found. Results...
Related topics: Cancer, Oncology, Medical Research

Read More →

Low-risk Ultrasound Procedure Revolutionizes Prostate Cancer Treatment

A new treatment shows promise for revolutionizing prostate cancer treatment, offering a minimally-invasive and relatively low-risk alternative to traditional surgeries and radiotherapies. Called TULSA, this method uses sound waves to eliminate the...
Related topics: Cancer, Oncology

Read More →

Medical News Today: Physical Activity May Protect Against Prostate Cancer

A large study that took a different approach has found that higher levels of physical activity could lower the risk of prostate cancer by 51%.
Related topics: Cancer, Oncology, Medical Research

Read More →

Reducing The Side-effects Of Prostate Hormone Therapy With Exercise

A prescription of short-term exercise for patients with advanced prostate cancer could help to reduce the side-effects of hormone therapy, according to new research. The trial aimed to reduce the adverse side-effects of hormone therapy such as...
Related topics: Hormones, Cancer, Oncology, Medical Research

Read More →

Docetaxel First May Boost Survival In Mcrpc

]]>(MedPage Today) -- WASHINGTON -- Sequencing docetaxel prior to second-generation androgen-blocking therapies may improve survival outcomes for men with metastatic castration-resistant prostate cancer (mCRPC), a retrospective study suggested...
Related topics: Cancer, Oncology, Medical Research

Read More →

Beta Blockers No Help In Advanced Prostate Cancer

]]>(MedPage Today) -- WASHINGTON -- A retrospective analysis of close to 40,000 men with high-risk prostate cancer treated at Veterans Affairs (VA) health systems found no association between beta blocker use and a reduction in mortality. While...
Related topics: Cancer, Oncology

Read More →

More Evidence That Aspirin Can Stave Off Death

]]>(MedPage Today) -- Taking aspirin as infrequently as 1 to 3 times a month reduced the risk of all-cause and cancer-related mortality in older adults in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial compared to no...
Related topics: Aspirin, Cancer, Colon Cancer, Lung Cancer, Ovarian Cancer, Colorectal Cancer, Oncology

Read More →

Mount Sinai Receives $1 Million Grant For Prostate Cancer Research

The Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai has received a $1 million grant from The Arthur M. Blank Family Foundation.
Related topics: Cancer, Oncology, Medical Research

Read More →

Organ Transplant Candidates With Prostate Cancer Diagnosis May Not Need To Delay Transplantation

New research led by a team from the University of Chicago Medicine suggests treatment guidelines for newly diagnosed prostate cancer patients who are waiting for an organ transplant or who are post-transplant.
Related topics: Cancer, Oncology, Medical Research

Read More →

Roswell Park Team Identifies New Tumor Suppressor Protein In Prostate Cancer

A research team led by Dr. Dean Tang at Roswell Park Comprehensive Cancer Center has identified the molecule LRIG1 as an important endogenous tumor suppressor in prostate cancer.
Related topics: Cancer, Proteins, Oncology, Medical Research

Read More →

Current Statin Use May Lower Risk For Lethal Prostate Cancer

MONDAY, Dec. 2, 2019 -- Current statin use is inversely associated with the risk for lethal prostate cancer, according to a study published online Nov. 21 in Clinical Cancer Research. Emma H. Allott, Ph.D., from Queen's University Belfast in the...
Related topics: Cancer, Oncology, Medical Research

Read More →

Prostate Cancer 'super Responders' Live For 2 Years On Immunotherapy

Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more on immunotherapy, a major clinical trial has shown. Researchers found that a small proportion of men were 'super responders' and...
Related topics: Cancer, Oncology, Clinical Trials, Medical Research

Read More →

Elton John Reveals He Wore And Used A Diaper On Stage Following Prostate Cancer Surgery

Musical legend, Sir Elton John, did an in-depth interview recently on BBC1 in which he revealed that while playing a Las Vegas, Nevada show just a few weeks after surgery for a prostate cancer issue, he not only secretly wore a diaper on stage, but...
Related topics: Cancer, Oncology

Read More →

Home Urine Test For Prostate Cancer Could Revolutionize Diagnosis

A simple urine test under development for prostate cancer detection can now use urine samples collected at home – according to new research from University of East Anglia and the Norfolk and Norwich University Hospital. Scientists pioneered...
Related topics: Cancer, Oncology, Medical Research

Read More →

Biennial Mammo Risky? Opioids And Cancer; Race Flaw In Prostate Ca Test?

]]>(MedPage Today) -- More fuel for the mammography debate: Breast cancers detected by biennial screening were more advanced as compared with cancers detected by annual mammographic screening. (Radiological Society of North America) Smoking rates...
Related topics: Breast Cancer, Cancer, Oncology, Mammography, Debate, Smoking

Read More →

Study Supports Psa Screening For Male Brca2 Carriers

WEDNESDAY, Nov. 27, 2019 -- Systematic prostate-specific antigen (PSA) screening is advised for men who are carriers of the BRCA2 mutation, which is associated with a higher incidence of prostate cancer, younger age at diagnosis, and clinically...
Related topics: Medical Research, Genetics, Cancer, Oncology

Read More →

Cancer Patients With Obesity Show Poorer Psychosocial Health

TUESDAY, Nov. 26, 2019 -- Patients with breast or prostate cancer who are obese score higher in psychosocial problem-related distress than nonobese patients, according to a study recently published in Psycho-Oncology. Errol J. Philip, M.D., Ph.D.,...
Related topics: Breast Cancer, Cancer, Oncology, Obesity, Medical Research

Read More →

Is Myovant's New Prostate Cancer Drug A Game Changer?

A number of biotech stocks have made major moves over the past week. One of those was Myovant Sciences (NYSE: MYOV), a $1.1 billion biopharma company, which had its shares more than double on Nov. 19 following impressive clinical trial results in...
Related topics: Cancer, Oncology, Clinical Trials

Read More →

Racial Differences Found In Gene Panels For Prostate Cancer Prognosis

MONDAY, Nov. 25, 2019 -- For three commercial panels for prostate cancer prognosis, gene expression differs for European-American men (EAM) and African-American men (AAM), according to a study published online Nov. 22 in Cancer Epidemiology,...
Related topics: Genetics, Cancer, Oncology, African-American, Medical Research

Read More →

New Research Shows How Use Of Cholesterol Lowering Drugs May Cut Risk Of Lethal Prostate Cancer

New research led by Queen's University Belfast has found that men who are on statins, medicine used to lower blood cholesterol, may have a reduced risk of developing a more lethal form of prostate cancer.
Related topics: Medical Research, Cholesterol, Cancer, Oncology

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.